{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T15:59:39Z","timestamp":1782230379753,"version":"3.54.5"},"reference-count":42,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Background\/Aim: The recovery pattern of hepatitis C virus (HCV)-associated metabolic alteration after sustained virological response (SVR) following direct-acting antivirals (DAAs) remains elusive. Methods: A prospective cohort study of chronic HCV-infected (CHC) patients (n = 415) receiving DAAs (n = 365) was conducted. Metabolic profiles were examined in SVR patients (n = 360) every 3\u20136 months after therapy and compared with those of sex- and age-matched controls (n = 470). Results: At baseline, of 415, 168 (40.5%) had insulin resistance (IR). The following were associated: levels of high-density lipoprotein cholesterol (HDL-C), triglycerides (TGs), HCV RNA, fibrosis-4 score, and interferon-\u03bb3-rs12979860 genotype with total cholesterol (TC) levels; and TG levels and BMI with HOMA-IR. Over a 3-year follow-up, in SVR patients, BMI and TC levels and TG\/HDL-C ratios increased from baseline, while HOMA-IR trended downward by 72 weeks after therapy and then increased. The increased HDL-C levels began to decrease after 72 weeks after therapy. TC and HOMA-IR were negatively associated with each other until 24 weeks after therapy. Earlier increases in BMI and decreases in HOMA-IR were noted in SVR patients with than in those without baseline IR. Compared with controls, in the subgroup without baseline IR, SVR patients had increased BMI and HOMA-IR levels. Metabolic profiles were similar between SVR patients and controls in the subgroup with baseline IR. Conclusions: In SVR patients treated with DAAs, the recovery of altered lipid and glucose metabolism was not coupled until 72-week post-therapy, when HOMA-IR reached its nadir. SVR patients with baseline IR recovered from HCV-associated metabolic alterations earlier than those without baseline IR.<\/jats:p>","DOI":"10.3390\/cells10112934","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T23:50:28Z","timestamp":1635465028000},"page":"2934","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Decoupled Glucose and Lipid Metabolic Recovery after Viral Clearance in Direct-Acting Antiviral-Treated HCV Patients: A 3-Year Prospective Cohort Study"],"prefix":"10.3390","volume":"10","author":[{"given":"Heng","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Medicine, College of Medicine, Chang Gung University, Taoyuan 333323, Taiwan"},{"name":"Department of Medicine, Taipei Veterans General Hospital, Taipei 112201, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Nan","family":"Chien","sequence":"additional","affiliation":[{"name":"Department of Medicine, College of Medicine, Chang Gung University, Taoyuan 333323, Taiwan"},{"name":"Division of Hepatology, Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Taoyuan 333423, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8081-7082","authenticated-orcid":false,"given":"Li-Heng","family":"Pao","sequence":"additional","affiliation":[{"name":"Graduate Institute of Health Industry Technology, Chang Gung University of Science and Technology, Taoyuan 33303, Taiwan"},{"name":"Research Center for Food and Cosmetic Safety and Research Center for Chinese Herbal Medicine, College of Human Ecology, Chang Gung University of Science and Technology, Taoyuan 33303, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Jung","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of Medicine, College of Medicine, Chang Gung University, Taoyuan 333323, Taiwan"},{"name":"Division of Hepatology, Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Taoyuan 333423, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Han","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Medicine, College of Medicine, Chang Gung University, Taoyuan 333323, Taiwan"},{"name":"Division of Hepatology, Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Taoyuan 333423, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4902-4401","authenticated-orcid":false,"given":"Ming-Ling","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Medicine, College of Medicine, Chang Gung University, Taoyuan 333323, Taiwan"},{"name":"Division of Hepatology, Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Taoyuan 333423, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/infdis\/jiy401","article-title":"Identification of a novel hepatitis c virus genotype from Punjab, India: Expanding classification of hepatitis c virus into 8 genotypes","volume":"218","author":"Borgia","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(19)32320-7","article-title":"Hepatitis C","volume":"394","author":"Spearman","year":"2019","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.3748\/wjg.v22.i4.1461","article-title":"Metabolic alterations and hepatitis C: From bench to bedside","volume":"22","author":"Chang","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Chang, M.L., and Yang, S.S. (2019). Metabolic signature of hepatic fibrosis: From individual pathways to systems biology. Cells, 8.","DOI":"10.3390\/cells8111423"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/jgh.12915","article-title":"Risk factors of hepatocellular carcinoma development in non-cirrhotic patients with sustained virologic response for chronic hepatitis C virus infection","volume":"30","author":"Toyoda","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.tem.2017.11.003","article-title":"Interacting cancer machineries: Cell signaling, lipid metabolism, and epigenetics","volume":"29","author":"Grunt","year":"2018","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","article-title":"Cancer-related inflammation and treatment effectiveness","volume":"15","author":"Diakos","year":"2014","journal-title":"Lancet Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jnci\/djz069","article-title":"Insulin resistance and cancer-specific and all-cause mortality in postmenopausal women: The women\u2019s health initiative","volume":"112","author":"Pan","year":"2020","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1440-1746.2004.03526.x","article-title":"Changes in serum lipid concentrations in patients with chronic hepatitis C virus positive hepatitis responsive or non-responsive to interferon therapy","volume":"20","author":"Hamamoto","year":"2005","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/bs.ai.2016.08.001","article-title":"Pleiotropic roles of type 1 interferons in antiviral immune responses","volume":"132","author":"Teijaro","year":"2016","journal-title":"Adv. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jhep.2011.01.011","article-title":"Hepatitis C virus resistance to protease inhibitors","volume":"55","author":"Halfon","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Doyle, M.A., Galanakis, C., Mulvihill, E., Crawley, A., and Cooper, C.L. (2019). Hepatitis C direct acting antivirals and ribavirin modify lipid but not glucose parameters. Cells, 8.","DOI":"10.3390\/cells8030252"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3851\/IMP3094","article-title":"Effect of antiviral therapy for HCV on lipid levels","volume":"21","author":"Mauss","year":"2017","journal-title":"Antivir. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"6150861","DOI":"10.1155\/2018\/6150861","article-title":"Chronic Hepatitis C association with diabetes mellitus and cardiovascular risk in the era of DAA therapy","volume":"2018","author":"Drazilova","year":"2018","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clinbiochem.2018.07.007","article-title":"Exploring lipid and apolipoprotein levels in chronic hepatitis C patients according to their response to antiviral treatment","volume":"60","author":"Lacerda","year":"2018","journal-title":"Clin. Biochem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"7845","DOI":"10.1038\/s41598-018-26293-9","article-title":"Eradication of hepatitis C virus is associated with the attenuation of steatosis as evaluated using a controlled attenuation parameter","volume":"8","author":"Shimizu","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1136\/gutjnl-2017-313832","article-title":"Favouring modulation of circulating lipoproteins and lipid loading capacity by direct antiviral agents grazoprevir\/elbasvir or ledipasvir\/sofosbuvir treatment against chronic HCV infection","volume":"67","author":"Sun","year":"2018","journal-title":"Gut"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Hashimoto, S., Yatsuhashi, H., Abiru, S., Yamasaki, K., Komori, A., Nagaoka, S., Saeki, A., Uchida, S., Bekki, S., and Kugiyama, Y. (2016). Rapid increase in serum low-density lipoprotein cholesterol concentration during hepatitis c interferon-free treatment. PLoS ONE., 11.","DOI":"10.1371\/journal.pone.0163644"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/14787210.2019.1653184","article-title":"HCV treatment with direct acting antivirals improves the insulin sensitivity","volume":"17","author":"Alsebaey","year":"2019","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/jgh.14067","article-title":"Hepatitis C virus clearance by direct-acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients","volume":"33","author":"Adinolfi","year":"2018","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.15403\/jgld.2014.1121.273.daa","article-title":"Impact of direct acting antiviral (DAA) treatment on glucose metabolism and reduction of pre-diabetes in patients with chronic hepatitis C","volume":"27","author":"Weidner","year":"2018","journal-title":"J. Gastrointestin. Liver Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/lt.25060","article-title":"Hepatitis C virus eradication with new interferon-free treatment improves metabolic profile in hepatitis c virus-related liver transplant recipients","volume":"24","author":"Beig","year":"2018","journal-title":"Liver Transpl."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jhep.2018.02.015","article-title":"Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis","volume":"69","author":"Petta","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1080\/21505594.2017.1300734","article-title":"The evolving relationship between adiponectin and insulin sensitivity in hepatitis C patients during viral clearance","volume":"8","author":"Chang","year":"2017","journal-title":"Virulence"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.7150\/jca.59133","article-title":"Pre-treatment high body mass index is associated with poor survival in Asian premenopausal women with localized breast cancer","volume":"12","author":"Lin","year":"2021","journal-title":"J. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2019). 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes\u20142019. Diabetes Care., 42, S13\u2013S28.","DOI":"10.2337\/dc19-S002"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Xu, X.L., Jiang, L.S., Wu, C.S., Pan, L.Y., Lou, Z.Q., Peng, C.T., Dong, Y., and Ruan, B. (2021). The role of fibrosis index FIB-4 in predicting liver fibrosis stage and clinical prognosis: A diagnostic or screening tool?. J. Formos. Med. Assoc.","DOI":"10.1016\/j.jfma.2021.07.013"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1590\/S1807-59322008000400003","article-title":"High ratio of triglycerides to HDL-cholesterol predicts extensive coronary disease","volume":"63","author":"Favarato","year":"2008","journal-title":"Clinics"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12944-019-1123-3","article-title":"Elevated triglyceride-to-HDL cholesterol ratio is an indicator for insulin resistance in middle-aged and elderly Taiwanese population: A cross-sectional study","volume":"18","author":"Yeh","year":"2019","journal-title":"Lipids Health Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.dsx.2018.10.006","article-title":"High triglycerides to HDL-cholesterol ratio is associated with insulin resistance in normal-weight healthy adults","volume":"13","year":"2019","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10238-013-0262-5","article-title":"The effect of the severity of liver cirrhosis on the level of lipids and lipoproteins","volume":"14","author":"Chrostek","year":"2014","journal-title":"Clin. Exp. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/hep.23592","article-title":"Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection","volume":"51","author":"Li","year":"2010","journal-title":"Hepatology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1053\/meta.2000.7735","article-title":"The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients","volume":"49","author":"Taniguchi","year":"2000","journal-title":"Metabolism"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/MCG.0000000000000400","article-title":"Insulin resistance is associated with significant liver fibrosis in chronic hepatitis c patients: A systemic review and meta-analysis","volume":"50","author":"Patel","year":"2016","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"747759","DOI":"10.1586\/eri.11.94","article-title":"Impact of HCV genetic differences on pathobiology of disease","volume":"9","author":"Ripoli","year":"2011","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/jmv.25062","article-title":"Effect of treatment with direct acting antivirals on body mass index and hepatic steatosis in chronic hepatitis C","volume":"90","author":"Shousha","year":"2018","journal-title":"J. Med. Virol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"788","DOI":"10.2337\/diacare.27.3.788","article-title":"Predictors of the incident metabolic syndrome in adults: The insulin resistance atherosclerosis study","volume":"27","author":"Palaniappan","year":"2004","journal-title":"Diabetes Care"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"9502643","DOI":"10.1155\/2017\/9502643","article-title":"Expanded normal weight obesity and insulin resistance in US adults of the national health and nutrition examination survey","volume":"2017","author":"Martinez","year":"2017","journal-title":"J. Diabetes Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1083\/jcb.201802095","article-title":"The cell biology of systemic insulin function","volume":"217","author":"Tokarz","year":"2018","journal-title":"J. Cell Biol."},{"key":"ref_41","first-page":"85","article-title":"Association of dyslipidemia, increased insulin resistance, and serum CA 15-3 with increased risk of breast cancer in urban areas of north and central India","volume":"9","author":"Kachhawa","year":"2018","journal-title":"J. Midlife Health."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"8728017","DOI":"10.1155\/2017\/8728017","article-title":"Insulin resistance and its association with metabolic syndrome in Korean children","volume":"2017","author":"Cho","year":"2017","journal-title":"Biomed. Res. Int."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/11\/2934\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:22:14Z","timestamp":1760167334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/11\/2934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,28]]},"references-count":42,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["cells10112934"],"URL":"https:\/\/doi.org\/10.3390\/cells10112934","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,28]]}}}